1. HBW Insight
  2. >>Ingredients & Safety

Bayer Extends Afrin Line With First OTC Oxymetazoline Spray In US For Children Under 6

 
• By Malcolm Spicer

Children’s Afrin regular and no-drip formulations reach US stores with consumers having choices between dozens of oxymetazoline nasal sprays available under an FDA OTC monograph. But products indicated for children was limited to one, Mucinex Childrens Stuffy Nose, and it’s for children 6 and up.

• Source: Shutterstock

Bayer AG doubles the number of children’s OTC oxymetazoline nasal sprays available in the US while offering the first indicated for children younger than 6 with the launch of Children’s Afrin Extra Moisturizing Stuffy Nose Spray in regular and no-drip formulations.

“As the leader of acute medicated nasal sprays, it was the right time for Afrin to begin expanding into the...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Ingredients & Safety

Gardenia Blue, OrangeOvation, StellarYellow Latest Natural Pivots In US Food Color Market

 
• By Malcolm Spicer

FDA’s fourth approval in past two months for color derived from natural sources to use in foods is Gardenia Blue Interest Group’s color additive petition for gardenia blue. Lycored launches StellarYellow and C Clear as alternatives for synthetic dyes yellow Nos. 5 and 6 and OrangeOvation C Clear for

House OMUFA Reauthorization Bill Takes On Clarifying Standards For Tests To Meet GRASE

 
• By Malcolm Spicer

Health Subcommittee will discuss reauthorizing OMUFA during a hearing on how to “maintain and improve” the public health workforce and rural health as well as access to OTC medicines.

Pharma Deutschland Seeks To Enter Urban Wastewater Legal Dispute

 
• By David Ridley

The Urban Wastewater Treatment Directive “in its current form, is at an end,” insists Pharma Deutschland CEO Jörg Wieczorek. To put the directive to bed once and for all, the association has applied for leave to intervene in the ongoing EU legal battle in its own right.

UK FSA Issues New Guidelines For CBD And THC Max Levels

 
• By David Ridley

Based on advice from its advisory committees, the UK's Food Standards Agency is encouraging businesses to meet an acceptable daily intake of 10mg CBD per day and a safe upper limit of 0.07mg THC per day.

More from HBW Insight

Beauty Deal Roundup: Ulta Acquires British Beauty Retailer SpaceNK, Unilever Picks Up Dr. Squatch

 
• By Eileen Francis

Illinois-based Ulta Beauty, Inc. acquires leading British beauty retailer SpaceNk from Manzanita Capital for an undisclosed price. Unilever PLC purchases Dr. Squatch personal care from Summit Partners.

People On The Move: Appointments At Opella, Stada, Futura

 
• By Tom Gallen

Latest European appointments: Opella names Germany director; Stada has new Western Europe head; Futura makes CEO change.

US FDA Extracts More Evidence To Ban Kratom

 
• By Malcolm Spicer

Recent warning letters to seven companies marketing products with kratom extract known as 7-OH are FDA’s first in three years referencing unlawful products containing kratom and the first of all its kratom-related warnings to reference extracts from the botanical.